EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients Ricardo RibeiroÂngelo SoaresRui Medeiros LAB INVESTIGATION 20 September 2006 Pages: 225 - 229
Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells Wei ZhangZhou FeiXiang Zhang Laboratory Investigation 20 September 2006 Pages: 231 - 240
PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium Robert M. BeatyJennifer B. EdwardsGregory J. Riggins LABORATORY INVESTIGATION 20 September 2006 Pages: 241 - 248
Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors Tapasya SrivastavaKunzang ChosdolSubrata Sinha Original Paper 04 October 2006 Pages: 249 - 255
Images in neuro-oncology: rapid development of osseous and chondrous metaplasia in recurrent anaplastic ependymoma Serguei BannykhJoachim M. Baehring Clinical–Patient Studies 13 October 2006 Pages: 257 - 258
Primary peripheral primitive neuroectodermal tumors of the spinal cord: report of two cases and review of the literature R. PerryI. GonzalesS. Zacharoulis Clinical–Patient Studies 03 January 2007 Pages: 259 - 264
Feasibility and response to 1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride chemotherapy with pre-treated procarbazine for elderly patients with newly diagnosed glioblastoma Mizuhiko TerasakiToshi AbeMinoru Shigemori Clinical – Patient studies 26 August 2006 Pages: 265 - 269
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme Morris D. GrovesVinay K. PuduvalliW. K. Alfred Yung Clinical – Patient Studies 22 September 2006 Pages: 271 - 277
Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine Anna Maria MauroChiara BomprezziMassimo Scerrati Clinical – Patient Studies 31 August 2006 Pages: 279 - 285
Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma Antje Ernst-SteckenOliver GanslandtGerhard Grabenbauer Clinical-Patient Studies 20 September 2006 Pages: 287 - 294
Prognostic factors for anaplastic astrocytomas Alessia CompostellaAlicia TosoniAlba A. Brandes Clinical–Patient Studies 26 September 2006 Pages: 295 - 303
Assessment of verbal working memory before and after surgery for low-grade glioma Pilar TeixidorPeggy GatignolHugues Duffau Clinical-Patient Studies 31 August 2006 Pages: 305 - 313
Clear cell Meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases D. JainM. C. SharmaA. K. Mahapatra Clinical–Patient Studies 06 September 2006 Pages: 315 - 321
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme Giuseppe Luigi BannaDaniela BettioArmando Santoro Letter to the Editor 23 September 2006 Pages: 323 - 325
Functional compensation of the claustrum: lessons from low-grade glioma surgery Hugues DuffauEmmanuel MandonnetLaurent Capelle Letter to the Editor 31 August 2006 Pages: 327 - 329